These findings support the potential clinical utility of copeptin as a risk stratification tool in sepsis management.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD42024587540. The gene discussed is AVP; the disease is Sepsis.